Alhadeff, PhD, senior study author After reviewing this study, Shruti Pandiri, MD, assistant professor of medicine in the Division of Endocrinology with the Center for Weight Loss & Metabolic Health at Hackensack University Medical Center in New Jersey, told MNT the findings of this study have the potential to lead to the development of GLP-1-based obesity drugs with improved tolerability
Surgical Body Contouring Options for Post-GLP-1 Patients Surgical intervention remains the most effective solution for significant excess skin after GLP-1 weight loss
The following general principles apply to subcutaneous self-injection, but you should always follow the specific instructions provided with your device and by your healthcare team, as details such as hold time, injection speed, and needle length are device-specific
Patients with epilepsy and other neuropsychiatric symptoms who receive cobalamin replacement therapy may resolve or even completely recover [84, 90,91,92,93]